Rand Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Rand Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,010	Closed	-$252K	–	218
2016 Q2	$252K	Hold	5,010	–	–	0.03%	205
2016 Q1	$268K	Hold	5,010	–	–	0.04%	196
2015 Q4	$329K	Sell	5,010 -17	-0.3%	-$1.05K	0.05%	189
2015 Q3	$284K	Buy	5,027 +17	+0.3%	+$1.1K	0.04%	196
2015 Q2	$296K	Hold	5,010	–	–	0.04%	186
2015 Q1	$312K	Hold	5,010	–	–	0.04%	187
2014 Q4	$296K	Sell	5,010 -50	-1%	-$2.79K	0.04%	190
2014 Q3	$272K	Hold	5,060	–	–	0.04%	180
2014 Q2	$265K	Hold	5,060	–	–	0.04%	180
2014 Q1	$267K	Sell	5,060 -835	-14%	-$38.6K	0.05%	174
2013 Q4	$236K	Sell	5,895 -15,000	-72%	-$591K	0.04%	182
2013 Q3	$789K	Hold	20,895	–	–	0.16%	121
2013 Q2	$819K	Buy	+20,895	New	+$814K	0.18%	115

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rand Wealth's TEVA Position: Q3 2016 in Review

Rand Wealth sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 5,010 shares — an estimated $252K sold.

Rand Wealth first reported a position in TEVA in Q2 2013 and held it in 13 quarters. The position peaked at $819K in Q2 2013. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Rand Wealth reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Rand Wealth sold 5,010 Teva Pharmaceuticals shares in Q3 2016, an estimated $252K.
Rand Wealth first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 13 quarters.
Rand Wealth's Teva Pharmaceuticals position peaked at $819K in Q2 2013.
795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Rand Wealth's 13F filing for Q3 2016, filed 4 Nov 2016.